Prior authorization requirements cause significant delays in cancer diagnosis and treatment, affecting 85% of surveyed patients.
Despite high approval rates, 29% of patients experienced diagnostic delays, and 40% faced treatment delays due to authorization processes.
For patients with cancer, prior authorization requirements and coverage stoppages generate barriers to life saving therapies and care, according to a first-of-its-kind national survey entitled "The Health Insurance Maze: How Cancer Patients Get Lost in the Red Tape of Utilization Management" from CancerCare.
In total, 1,201 patients with cancer were surveyed, revealing unnecessary insurance "red tape". Insurance companies required 85% of the patients surveyed to receive prior authorization before receiving a doctor-prescribed cancer treatment, 76% of which were in the last year alone. These delays can cause significant time burdens and stress for these patients, during a time when they are already delay with a serious illness.
www.curetoday.com
Despite high approval rates, 29% of patients experienced diagnostic delays, and 40% faced treatment delays due to authorization processes.
For patients with cancer, prior authorization requirements and coverage stoppages generate barriers to life saving therapies and care, according to a first-of-its-kind national survey entitled "The Health Insurance Maze: How Cancer Patients Get Lost in the Red Tape of Utilization Management" from CancerCare.
In total, 1,201 patients with cancer were surveyed, revealing unnecessary insurance "red tape". Insurance companies required 85% of the patients surveyed to receive prior authorization before receiving a doctor-prescribed cancer treatment, 76% of which were in the last year alone. These delays can cause significant time burdens and stress for these patients, during a time when they are already delay with a serious illness.
How Insurance Red Tape Threatens Timely Cancer Care
A study explores how prior authorization requirements; coverage stoppages and other red tape can generate barriers to life saving therapies in cancer care.
